Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1055/a-1300-2550 http://scihub22266oqcxt.onion/10.1055/a-1300-2550 33207372!7781662!33207372     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33207372&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Horm+Metab+Res 2021 ; 53 (1): 9-15 Nephropedia Template TP {{tp|p=33207372|t=2021. The Role of Glucocorticoids in the Management of COVID-19 |pdf=|usr=}}{{33207372}} gab.com Text The Role of Glucocorticoids in the Management of COVID-19 JO: Horm Metab Res http://www.kidney.de/pget.php?&tw=1&pmid=33207372 #FOAvip Coronavirus disease 2019 (COVID-19), caused by an infection with the novel coronavirus SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health systems worldwide. COVID-19 is highly infectious and is characterized by an acute respiratory illness that varies from mild flu-like symptoms to the life-threatening acute respiratory distress syndrome (ARDS). As such, there is an urgent need for the development of new therapeutic strategies, which combat the high mortality in severely ill COVID-19 patients. Glucocorticoids are a frontline treatment for a diverse range of inflammatory diseases. Due to their immunosuppressive functions, the use of glucocorticoids in the treatment of COVID-19 patients was initially regarded with caution. However, recent studies concluded that the initiation of systemic glucocorticoids in patients suffering from severe and critical COVID-19 is associated with lower mortality. Herein we review the anti-inflammatory effects of glucocorticoids and discuss emerging issues in their clinical use in the context of COVID-19. Twit Text FOAVip The Role of Glucocorticoids in the Management of COVID-19 ????Horm Metab Res http://www.kidney.de/pget.php?&tw=1&pmid=33207372 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33207372 #FOAvip English Wikipedia <ref>{{Cite pmid|33207372}}</ref> The Role of Glucocorticoids in the Management of COVID-19 #MMPMID33207372 Alexaki VI; Henneicke H Horm Metab Res 2021[Jan]; 53 (1): 9-15 PMID33207372show ga Coronavirus disease 2019 (COVID-19), caused by an infection with the novel coronavirus SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health systems worldwide. COVID-19 is highly infectious and is characterized by an acute respiratory illness that varies from mild flu-like symptoms to the life-threatening acute respiratory distress syndrome (ARDS). As such, there is an urgent need for the development of new therapeutic strategies, which combat the high mortality in severely ill COVID-19 patients. Glucocorticoids are a frontline treatment for a diverse range of inflammatory diseases. Due to their immunosuppressive functions, the use of glucocorticoids in the treatment of COVID-19 patients was initially regarded with caution. However, recent studies concluded that the initiation of systemic glucocorticoids in patients suffering from severe and critical COVID-19 is associated with lower mortality. Herein we review the anti-inflammatory effects of glucocorticoids and discuss emerging issues in their clinical use in the context of COVID-19. |*COVID-19 Drug Treatment[MESH] |*SARS-CoV-2[MESH] |Anti-Inflammatory Agents/*therapeutic use[MESH] |Glucocorticoids/*therapeutic use[MESH] |Humans[MESH] |Immunosuppressive Agents/*therapeutic use[MESH]The Role of Glucocorticoids in the Management of COVID-19 (epmc).pdf DeepDyve Pubget Overpricing